Download PDF
Drug Res (Stuttg) 2014; 64(6): 321-329
DOI: 10.1055/s-0033-1358702
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Development and Validation of Liquid Chromato­graphy-Tandem Mass Spectrometric Method for Quantification of Meropenem in Rat Plasma and its Application in a Preclinical Dose Proportionality Study

B. K. Chaursia
1   Metabolism and Pharmacokinetics, Department of Clinical Pharmacology & Pharmacokinetics, Ranbaxy Laboratories Limited, Haryana, India
,
T. P. Singh
1   Metabolism and Pharmacokinetics, Department of Clinical Pharmacology & Pharmacokinetics, Ranbaxy Laboratories Limited, Haryana, India
,
B. Varshney
1   Metabolism and Pharmacokinetics, Department of Clinical Pharmacology & Pharmacokinetics, Ranbaxy Laboratories Limited, Haryana, India
,
P. Sharma
1   Metabolism and Pharmacokinetics, Department of Clinical Pharmacology & Pharmacokinetics, Ranbaxy Laboratories Limited, Haryana, India
,
S. S. Iyer
1   Metabolism and Pharmacokinetics, Department of Clinical Pharmacology & Pharmacokinetics, Ranbaxy Laboratories Limited, Haryana, India
,
A. H. Khuroo
1   Metabolism and Pharmacokinetics, Department of Clinical Pharmacology & Pharmacokinetics, Ranbaxy Laboratories Limited, Haryana, India
,
T. Monif
1   Metabolism and Pharmacokinetics, Department of Clinical Pharmacology & Pharmacokinetics, Ranbaxy Laboratories Limited, Haryana, India
› Author Affiliations
Further Information

Publication History

received 01 June 2013

accepted 16 October 2013

Publication Date:
13 November 2013 (online)

Also available at
    Permissions and Reprints

Abstract

A simple, rapid, sensitive and selective assay based liquid chromatography-tandem mass spectrometric method was developed and validated for quantitative analysis of meropenem in rat plasma using rolipram as internal standard. Efficient chromatographic separation of analyte from matrix components was achieved by using Kromasil 100 C18 (150×4.6 mm, 5 µm) reversed phase column with mobile phase consisting of acetonitrile and 2 mM ammonium acetate buffer (80:20, v/v) delivered in isocratic mode with constant flow rate of 0.7 mL/min. Detection of meropenem and rolipram was performed in positive mode using multiple reaction monitoring (MRM). The mass transitions 384.1→141.0 and 276.2→191.1 were used to quantify meropenem and rolipram, respectively. A fast and simple solid phase extraction method was optimized for extraction of meropenem from rat plasma. The developed method was validated for selectivity, accuracy, precision, linearity, recovery, stability, matrix effect, dilution integrity as per regulatory guidelines. The developed method was selective with no interfering components at the retention time of meropenem and rolipram. The assay demonstrated acceptable linearity (R2>0.99) over a dynamic range of 0.19–201.40 µg/mL. The method exhibited excellent and acceptable precision and accuracy, and produced consistent recoveries. The method demonstrated excellent stability of meropenem in rat plasma under studied conditions investigated. Finally, the validated method was successfully applied to quantify meropenem levels in rat plasma of a dose escalation study.

Key words

meropenem - solid phase extraction - validation - rat plasma - dose proportionality study - LC-MS/MS
 

  • References

  • 1 Yong SKM, Karen CC, Mark AG. Pharmacokinetics of meropenem in animals, healthy volunteers, and patient. Clin Infect Disease 1997; 24: 249-255
    CrossrefPubMedSearch in Google Scholar
  • 2 Claudine MB, Katherine ALW, Susan JK. Meropenem – A Review of its Use in the Treatment of Serious Bacterial Infections Drugs. 2008; 68: 803-838
    PubMedSearch in Google Scholar
  • 3 Dupuis A, Minet P, Couet W et al. Rapid and sensitive Determination of meropenem in rat plasma by high performance liquid chromatography. J Liq Chrom Rel Technol 1998; 21: 2549-2560
    CrossrefPubMedSearch in Google Scholar
  • 4 Wagenlehner FME, Naber KG. Current challenges in the treatment of complicated urinary tract infections and prostatitis. Clin Microbial Infect 2006; 12: 67-80
    CrossrefPubMedSearch in Google Scholar
  • 5 Jeffrey LB. Meropenem: evaluation of a new generation carbapenem. Int J Antimicrob Agents 1997; 8: 73-92
    CrossrefPubMedSearch in Google Scholar
  • 6 Mouton JW, Vanden AJN. Meropenem clinical pharmacokinetics. Clin Pharmacokinet 1995; 28: 275-286
    CrossrefPubMedSearch in Google Scholar
  • 7 Farin D, Kitzes CR, Piva G et al. High performance liquid chromatography method for the determination of meropenem in human plasma. Chromatographia 1999; 49: 253-255
    CrossrefPubMedSearch in Google Scholar
  • 8 Elkhaili H, Niedergang S, Pompei D et al. High-performance liquid chromatographic assay for meropenem in serum. J Chrom B Biomedical Sciences and Applications 1996; 686: 19-26
    PubMedSearch in Google Scholar
  • 9 Chang YL, Chou MH, Lin MF et al. Determination and pharmacokinetic study of meropenem in rat bile using on-line microdialysis and liquid chromatography. J Chromatogr A 2002; 961: 119-124
    CrossrefPubMedSearch in Google Scholar
  • 10 Keiko K, Kazuro I, Kayo I et al. HPLC Method for Measuring Meropenem and Biapenem Concentrations in Human Peritoneal Fluid and Bile: Application to Comparative Pharmacokinetic Investigations. J Chromatogr Sci 2010; 48: 406-411
    CrossrefPubMedSearch in Google Scholar
  • 11 Lee HS, Shim HO, Yu SR. High performance liquid chromatographic determination of Meropenem in rat plasma using column switching. Chromatographia 1996; 42: 405-408
    CrossrefPubMedSearch in Google Scholar
  • 12 Andreas SLM, Martin S, Elfrides ESS. Validation of HPLC and UV spectrophotometric methods for the determination of meropenem in pharmaceutical dosage form. J Pharm Biomed Anal 2003; 33: 947-954
    CrossrefPubMedSearch in Google Scholar
  • 13 Tomoko M, Kazuro I, Kayo I et al. LC Method for the Determination of Meropenem in Cerebrospinal Fluid: Application to Therapeutic Drug Monitoring. Chromatographia 2009; 69: 1031-1034
    CrossrefPubMedSearch in Google Scholar
  • 14 Raphael D, Corinne C. Simultaneous determination of five β-lactam antibiotics (cefepim, ceftazidim, cefuroxim, meropenem and piperacillin) in human plasma by high-performance liquid chromatography with ultraviolet detection. J Chrom B 2008; 864: 161-167
    CrossrefPubMedSearch in Google Scholar
  • 15 Wolfgang AK, Jurgen B, Martina KS et al. Evaluation by Monte Carlo Simulation of the Pharmacokinetics of Two Doses of Meropenem Administered Intermittently or as a Continuous Infusion in Healthy Volunteers. Antimicrob Agents Chemother 2005; 49: 1881-1889
    CrossrefPubMedSearch in Google Scholar
  • 16 Ronald N, Christoph L, Martina KS et al. Disposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy. Antimicrob Agents Chemother 1998; 42: 2012-2016
    PubMedSearch in Google Scholar
  • 17 US Department of Health and Human Services . Food and Drug Administration Centre for Drug Evaluation and Research (CDER). Rockville, MD: Guidance for Industry: Bioanalytical Method Validation; 2001
    Search in Google Scholar